Effects of dichloroacetate and ubiquinone infusions on glycolysis activity and thermal sensitivity during sepsis

Journal of Laboratory and Clinical Medicine

Volumn 143, Issue 6, 2004, Pages 352-357

  L'Her, Erwan ^a   Sebert, Philippe ^b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b NONE

Author keywords

aerobic glycolytic flux; cecal ligation and perforation; CLP; coenzyme Q10 (ubiquinone); CoQ10; DCA; dichloroacetate; G6P; glucose 6 phosphate; HEPES; JA; JB; N 2 hydroxyethylpiperazine N 2 ethanesulfonic acid

Indexed keywords

DICHLOROACETIC ACID; GLUCOSE; LACTIC ACID; PYRUVATE DEHYDROGENASE; SODIUM CHLORIDE; UBIDECARENONE; UBIQUINONE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; GLYCOLYSIS; LACTATE BLOOD LEVEL; MALE; METABOLIC DISORDER; NONHUMAN; RAT; RAT STRAIN; SEPSIS; TEMPERATURE SENSITIVITY;

ANIMALS; BODY TEMPERATURE REGULATION; DICHLOROACETATE; ELECTRON TRANSPORT COMPLEX III; ENZYME ACTIVATION; GLUCOSE; GLYCOLYSIS; INFUSIONS, INTRAVENOUS; LACTIC ACID; MALE; MITOCHONDRIA; MUSCLE, SKELETAL; PYRUVATE DEHYDROGENASE COMPLEX; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; UBIQUINONE;

EID: 3042831438     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2004.03.004     Document Type: Article

References (39)

1. Gutierrez G., Wulf M.E. Lactic acidosis in sepsis a commentary. Intensive Care Med. 22:1996;6-16
2. Mizock B. Metabolic derangements in sepsis and septic shock. Crit Care Clin. 16:2000;319-336
3. L'Her E., Sébert P. A global approach to energy metabolism in an experimental model of sepsis. Am J Respir Crit Care Med. 164:2001;1444-1447
4. Singer M., Brealey D. Mitochondrial dysfunction in sepsis. Biochem Soc Symp. 66:1999;149-166
5. Gellerich F.N., Trumbeckaite S., Hertel K., Zierz S., Müller-Werdan U., Werdan K., et al. Impaired energy metabolism in hearts of septic baboons diminished activities of complex I and complex II of the mitochondrial respiratory chain. Shock. 11:1999;336-341
6. Mela-Riker L., Tavakoli H. Mitochondrial function in shock. Am J Emerg Med. 2:1984;2-7
7. Sébert P., Kervran C., L'Her E. Temperature sensitivity of glycolysis during sepsis. Crit Care Med. 31:2003;246-249
8. Welty-Wolf K.E., Simonson S.G., Huang Y.T., Fracica P.J., Patterson J.W., Piantadosi C.A. Ultrastructural changes in skeletal muscle mitochondria in gram-negative sepsis. Shock. 5:1996;378-384
9. Mela-Riker L., Bartos D., Vleiss A.A., Widner L., Muller P., Trunkey D.D. Chronic hyperdynamic sepsis in the rat. II. Characterization of liver and muscle energy metabolism. Circ Shock. 36:1992;83-92
10. 10 deficiency. Lancet. 356:2000;391-395
11. Folkers K., Simonsen R. Two successful double-blind trials with coenzyme Q10 (vitamin Q10) on muscular dystrophies and neurogenic atrophies. Biochim Biophys Acta. 1271:1995;281-286
12. Vary T.C., Hazen S. Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle. Mol Cell Biochem. 198:1999;113-118
13. Howard James J., Luchette F.A., McCarter F.D., Fischer J.E. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet. 354:1999;505-508
14. De Backer D., Creteur J., Zhang H., Norrenberg M., Vincent J.L. Lactate production by the lung in acute lung injury. Am J Respir Crit Care Med. 156:1997;1099-1104
15. Kemper W.F., Lindstedt S.L., Hartzler L.K., Hicks J.W., Conley K.E. Shaking up glycolysis sustained high lactate flux during aerobic rattling. Proc Natl Acad Sci U S A. 98:2001;723-728
16. Fagan J.M., Ganguly M., Tiao G., Fischer J.E., Hasselgren P.O. Sepsis increases oxidatively damaged protein in skeletal muscles. Arch Surg. 131:1996;1326-1332
17. Chaudry I.H., Wichterman K.A., Baue A.E. Effect of sepsis on tissue adenine nucleotide levels. Surgery. 85:1979;205-211
18. Neviere R.R., Cepinskas G., W.S., Madorin W.S., Hoque N., Karmazyn M., Sibbald W.J., et al. LPS pre-treatment ameliorates peritonitis-induced myocardial inflammation and dysfunction role of myocytes. Am J Physiol. 277:1999;H885-892
19. L'Her E., Sébert P. Glycolysis in the human skeletal muscle a new approach. J Lab Clin Med. 136:2000;281-286
20. Wu X., Stezoski J., Safar P., Bauer A., Tuerler A., Schwarz N., et al. Mild hypothermia during hemorrhagic shock in rats improves survival without significant effects on inflammatory responses. Crit Care Med. 31:2003;195-202
21. Stacpoole P.W., Wright E.C., Baumgartner T.G., Bersin R.M., Buchalter S., Curry S.H., et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. N Engl J Med. 327:1992;1564-1569
22. Mizock B.A., Falk J.L. Lactic acidosis in critical illness. Crit Care Med. 20:1992;80-93
23. Ribes G., Vallete G., Loubtaireres-Mariani M.M. Metabolic effects of sodium dichloroacetate in normal and diabetic dogs. Diabetes. 28:1979;852-857
24. Stacpoole P.W., Harman E.M., Curry S.H., Baumgartnet T.G., Misbin R.I. Treatment of lactic acidosis with dichloroacetate. N Engl J Med. 309:1983;390-396
25. Stacpoole P.W., Lorenz A.C., Thomas R.G., Harman E.M. Dichloroacetate in the treatment of lactic acidosis. Ann Intern Med. 108:1988;58-63
26. Lantum H.B., Baggs R.B., Krenitsky D.M., Anders M.W. Nephrotoxicity of chlorofluoroacetic acid in rats. Toxicol Sci. 70:2002;261-268
27. Pereira M.A., Kramer P.M., Conran P.B., Tao L. Effect of chloroform on dichloroacetic acid and trichloroacetic acid-induced hypomethylation and expression of the c-myc gene and on their promotion of liver and kidney tumors in mice. Carcinogenesis. 22:2001;1511-1519
28. Bersin R.M., Stacpoole P.W. Dichloroacetate as metabolic therapy for myocardial ischemia and failure. Am Heart J. 134:1997;841-855
29. Lewis J.F., DaCosta M., Wargowich T., Stacpoole P. Effects of dichloroacetate in patients with congestive heart failure. Clin Cardiol. 21:1998;888-892
30. Shangraw R.E., Winter R., Hromco J., Robinson S.T., Gallaher E.J. Amelioration of lactic acidosis with dichloroacetate during liver transplantation in humans. Anesthesiology. 81:1994;1127-1138
31. Wargovich L.J., MacDonald R.G., Hill J.A., Feldman R.L., Stacpoole P.W., Pepine C.J. Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. Am J Cardiol. 61:1988;65-70
32. Lewis J.F., DaCosta M., Wargowich T., Stacpoole P. Effects of dichloroacetate in patients with congestive heart failure. Clin Cardiol. 21:1998;888-892
33. Burns A.H., Giaimo M.E., Summer W.R. Dichloroacetic acid improves in vitro myocardial function following in vivo endotoxin administration. J Crit Care. 1:1986;11-17
34. Watmough N.J., Birch-Machin M.A., Bindoff L.A., Aynsley-Green A., Simpson K., Ragan C.I., et al. Tissue specific defect of complex I of the mitochondrial respiratory chain. Biochem Biophys Res Commun. 160:1989;623-627
35. Brooks H., Krähenbühl S. Development of a new assay for complex I of the respiratory chain. Clin Chem. 46:2000;345-350
36. Crestanello J.A., Doliba N.M., Babsky A.M., Niborii K., Osbakken M.D., Whitman G.J. Effect of coenzyme Q10 supplementation on mitochondrial function after myocardial ischemia reperfusion. J Surg Res. 102:2002;221-228
37. Niibori K., Wroblewski K.P., Yokoyama H., Crestanello J.A., Whitman G.J. Bioenergetic effect of liposomal coenzyme Q10 on myocardial ischemia reperfusion injury. Biofactors. 9:1999;307-313
38. Lelli J.L., Drongowski R.A., Gastman B., Remick D.G., Coran A.G. Effects of coenzyme Q10 on the mediator cascades of sepsis. Circ Shock. 39:1993;178-187
39. Yasumoto K., Inada Y. Effect of coenzyme Q10 on endotoxin shock in dogs. Crit Care Med. 14:1986;570-574